Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats.
Li Q, Fang Y, Peng DW, Li LA, Deng CY, Yang H, Kuang SJ, Li QQ, Zhang MZ, Zeng P, Zhang QH, Liu Y, Deng H, Wei W, Xue YM, Wu SL, Rao F.
Li Q, et al. Among authors: xue ym.
Eur J Pharmacol. 2023 Aug 5;952:175754. doi: 10.1016/j.ejphar.2023.175754. Epub 2023 May 12.
Eur J Pharmacol. 2023.
PMID: 37182595